Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Kit de diagnóstico precoz y pronóstico del cáncer de páncreas

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOES20150821001
Publicado:
01/09/2015
Caducidad:
31/08/2016
Resumen:
Un grupo español de investigación médica ha desarrollado un kit de diagnóstico precoz y pronóstico del cáncer de páncreas que analiza la respuesta al tratamiento del cáncer mediante métodos de reconocimiento cualitativo y cuantitativo de patrones. El kit también incluye los elementos necesarios para analizar el nivel de expresión de genes seleccionados relacionados con el diagnóstico precoz, pronóstico y respuesta al tratamiento. Se buscan compañías farmacéuticas o biotecnológicas con experiencia en diagnóstico del cáncer para licenciar la tecnología.

Details

Tittle:
Kit for early diagnosis and prognosis of pancreatic cancer
Summary:
A Spanish medical research group has developed a kit for the early diagnosis and prognosis of pancreatic cancer and to analyse the response to the treatment of the cancer. The group is looking for pharmaceutical or biotech companies experienced in cancer diagnostics for licensing the technology.
Description:
Pancreatic cancers are the seventh most common cause of cancer deaths, resulting in 330,000 deaths globally, occurring most often in the developed world, where about 70% of the new cases originated. Since it is one of the cancer types with the lowest survival rates, the early diagnosis is of especial relevance for the patient.

In order to address this issue a Spanish medical research group has developed a kit for the early diagnosis and prognosis of pancreatic cancer and to analyse the response to the treatment of the cancer.
The kit obtains data for the early diagnosis of pancreatic cancer and evaluates the response to the treatment of the disease by qualitative and quantitative single pattern recognition methods. The kit furthermore comprises the needed elements to analyse the expression level of selected genes which are related with the early diagnosis, prognosis and the treatment response.

The kit works in a non invasive way for the patient and was tested and validated on a group with cancer and non cancer patients in a mayor hospital. The research group is now looking for pharmaceutical or biotech companies experienced in cancer diagnostics for licensing the technology.

Advantages and Innovations:
- Accurate prognostic and diagnostic of pancreatic cancer in its early stage

- Treatment response prediction which allows to group patients and avoids unnecessary or ineffective treatments

- Analysis is non invasive for the patient

- Kit tested and validated on a group of hospital patients.
Stage of Development:
Field tested/evaluated
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
PCT international patent application filed

Partner sought

Type and Role of Partner Sought:
- Type of partner sought: pharmaceutical or biotech companies.

- Specific area of activity of the partner: Cancer diagnostics

- Task to be performed by the partner sought: licensing for further development to bring the technology to the market

Client

Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English
Spanish

Keywords

Technology Keywords:
06001003 Citología, cancerología, oncología
06001012 Investigaciones médicas